ANGELA WHITE: Open Payments
NPI 1700397627 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 33 payments from 17 companies in 2025. Trend: 2023 $505 · 2024 $466 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $192 |
| Lilly USA, LLC | 5 | $75 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Novo Nordisk Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| ViiV Healthcare Company | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $18 |
| Sonex Health, Inc. | 1 | $17 |
Products named: QULIPTA, MOUNJARO, UBRELVY, Symbravo, CAPLYTA, Ozempic, Veozah, APRETUDE.
Industry payments across UT — which companies pay providers there.
